Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myelodysplastic Syndromes 22Leukemia 21Lymphoma, Non-Hodgkin 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Recurrence 7Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma 5Congenital Abnormalities 5Anemia, Refractory, with Excess of Blasts 5Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Hematologic Neoplasms 3Graft vs Host Disease 3Burkitt Lymphoma 3Neoplasms 2Neoplasm, Residual 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Bone Marrow Failure Disorders 2

Interventions

midostaurin 2pegfilgrastim 1glofitamab 1Topotecan 1Prednisone 1Paclitaxel 1Methylprednisolone 1Immunologic Techniques 1Flow Cytometry 1Clofarabine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Aggression × Clofarabine × Clear all
NCT00201669 2017-12-06

A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
6 enrolled
Lymphoid

Aggression, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡